We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Research · December 06, 2022

Predictive Value of Tumour-Associated Stroma for Poor Clinical Outcomes and Immunoevasive Contexture in Patients With Upper Tract Urothelial Carcinoma

British Journal of Cancer


Additional Info

British Journal of Cancer
The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study)
Br. J. Cancer 2022 Nov 17;[EPub Ahead of Print], L Xu, W Zhong, C Li, P Hong, K Xia, R Lin, S Cheng, B Wang, M Yang, J Chen, L Ma, X Li, L Zhou, J Huang, T Lin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading